MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants

Last updated: August 21, 2025
Sponsor: Duke University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback

Clinical Study ID

NCT05929898
Pro00112672
1R01MH131667-01
  • Ages 18-45
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this research study is to understand how healthy individuals self-regulate motivation by observing brain activity using magnetic resonance imaging (MRI).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 18 and 45 years

  • Male or female

  • Right-handed

  • In good general health

  • Women of childbearing capacity: use of effective method of birth control

Exclusion

Exclusion Criteria:

  • Current or diagnosis within past six months of an DSM-V Axis I or Axis II disorder (self-reported)

  • CES-D score of 20 or higher (indicating significant current depression symptoms)

  • Current or past six month use of prescription medications indicated for psychiatricconditions (e.g.,depression, anxiety)

  • Current serious medical illness (self-reported)

  • Head injury resulting in loss of consciousness

  • For participants age > 59 years, a total scaled score < 8 on the Dementia RatingScale-2.

  • A clinically-defined neurological disorder including, but not limited to:

  • Any condition likely to be associated with increased intracranial pressure

  • Space occupying brain lesion

  • History of stroke

  • Transient ischemic attack within two years

  • Cerebral aneurysm

  • Dementia

  • Mini Mental Status Exam (MMSE) score of <24

  • Parkinson's disease

  • Huntington's disease

  • Multiple sclerosis

  • Presence of cochlear implants or other implanted electronic devices or non-removablemetal (e.g., non-removable piercing, IUD)

  • History of an eye injury involving metal. Participants who worked with metal may beallowed to participate on a case-by-case basis with prior written approval fromBIAC.

  • Claustrophobia or unwillingness to tolerate the confinement associated with being inthe MRI scanner.

  • Weight of more than 250 pounds

Study Design

Total Participants: 190
Treatment Group(s): 1
Primary Treatment: Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
Phase:
Study Start date:
July 30, 2023
Estimated Completion Date:
September 09, 2026

Study Description

Neuromodulatory nuclei detect and transform brain network activity into simpler signals, then send neurotransmitters back out to large-scale brain networks to change their function. Such nuclei are centrally implicated in mental disorders and adaptive resilience, and their regulation remains an untapped resource for interventions. The purpose of this study is to understand how neuromodulatory nuclei detect and in turn influence distributed patterns of brain activity to impact behavior. In order to understand their regulation and effects on brain function, the investigative team has developed novel neuroimaging, behavioral, and analytic methods. These methods include: training participants to endogenously self-regulate dopaminergic midbrain and then relating midbrain activation to memory-conducive states, effort exertion, and decision making.

If the aims of this project are achieved, the investigators will have methods for regulating midbrain noninvasively, an improved understanding of its impact on learning and motivated behavior, and reliable cognitive strategies for a wide array of interventions across educational and clinical applications.

Connect with a study center

  • Center for Cognitive Neuroscience

    Durham, North Carolina 27708
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.